Insulin resistance uncoupled from dyslipidemia due to C-terminal PIK3R1 mutations-Reference-Cited by-同舟云学术

Insulin resistance uncoupled from dyslipidemia due to C-terminal PIK3R1 mutations

Published:2016-10-20 Issue:17 Volume:1 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Huang-Doran Isabel,Tomlinson Patsy,Payne Felicity,Gast Alexandra,Sleigh Alison,Bottomley William,Harris Julie,Daly Allan,Rocha Nuno,Rudge Simon,Clark Jonathan,Kwok Albert,Romeo Stefano,McCann Emma,Müksch Barbara,Dattani Mehul,Zucchini Stefano,Wakelam Michael,Foukas Lazaros C.,Savage David B.,Murphy Rinki,O’Rahilly Stephen,Barroso Inês,Semple Robert K.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference57 articles.

1. Critical nodes in signalling pathways: insights into insulin action;Taniguchi;Nat Rev Mol Cell Biol,2006

2. A role for insulin in the aetiology and course of hypertension?;Reaven;Lancet,1987

3. Decreased IRS-2 and Increased SREBP-1c Lead to Mixed Insulin Resistance and Sensitivity in Livers of Lipodystrophic and ob/ob Mice

4. Insulin resistance differentially affects the PI 3-kinase– and MAP kinase–mediated signaling in human muscle

5. Regulation of Hepatic De Novo Lipogenesis in Humans

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the role of PIK3R1 in cancer: A comprehensive review of regulatory signaling and therapeutic implications;Seminars in Cancer Biology;2024-11

2. Methyl vinyl ketone and its analogs covalently modify PI3K and alter physiological functions by inhibiting PI3K signaling;Journal of Biological Chemistry;2024-03

3. The metabolically protective energy expenditure increase ofPik3r1-related insulin resistance is not explained by Ucp1-mediated thermogenesis;2024-02-12

4. Alterations of the AKT Pathway in Sporadic Human Tumors, Inherited Susceptibility to Cancer, and Overgrowth Syndromes;Current Topics in Microbiology and Immunology;2024

5. Paradoxical dominant negative activity of an immunodeficiency-associated activatingPIK3R1variant;2023-11-02